ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
Project Title | Institution / Principal Investigator(s) | Grant Type | Year | State |
---|---|---|---|---|
Identification of proteins interacting with ALK in neuroblastoma. | Dana-Farber Cancer Institute / Rani George | Young Investigator Grants | 2009 | Massachusetts |
Genetic Regulators of ER Stress-induced Apoptosis in Pediatric Malignancies | Dana-Farber Cancer Institute / Ujwal Pyati | Young Investigator Grants | 2009 | Massachusetts |
Development of a childhood leukemia translational research program. | Dana-Farber Cancer Institute / Lewis Silverman | Phase I/II Infrastructure Grants | 2009 | Massachusetts |
Metabolic control of p53 activation in T-ALL. | Duke University / Jeffrey Rathmell | Innovation Grants | 2009 | North Carolina |
Modeling anaplastic medulloblastoma using cerebellar stem cells | Duke University / Robert Wechsler-Reya, PhD | Innovation Grants | 2009 | North Carolina |
Aberrant DNA methylation in Ewing sarcoma. | Fred Hutchinson Cancer Research Center / Scott Borinstein | Young Investigator Grants | 2009 | Washington |
Targeted regulation of acetylation as novel therapy for Ewing sarcoma. | Georgetown University / Jeffrey Toretsky | Innovation Grants | 2009 | District of Columbia |
Molecular diagnostic, prognostic, and therapeutic approaches toward Ewing sarcoma. | Huntsman Cancer Institute / Stephen Lessnick | Innovation Grants | 2009 | Utah |
GSTM4, a novel target for treating Ewing sarcoma. | Huntsman Cancer Institute / Wen Luo | Young Investigator Grants | 2009 | Utah |
Identification of FDA approved drugs with anti-tumor activity in rhabdomyosarcoma. | Massachusetts General Hospital / David Langenau | Young Investigator Grants | 2009 | Massachusetts |